TACSTD2 and breast cancer: Emphasizing the necessity for more in-depth research to elucidate TROP2’s molecular mechanisms and navigate the obstacles in developing effective TROP2-targeted therapies, we aim to uplift patient outcomes and reshape breast cancer treatment paradigms.